Sacubitril/Valsartan and implantable cardioverter- -defibrillators: evolving therapeutic strategies. A case report-Reference-Cited by-同舟云学术

Sacubitril/Valsartan and implantable cardioverter- -defibrillators: evolving therapeutic strategies. A case report

Published:2020-11-01 Issue:5 Volume:62 Page:479-482
ISSN:0010-8650
Container-title:Cor et Vasa
language:
Short-container-title:Cor Vasa

Author:

Morabito Claudia,De Fazio Marianna Gigliotti,Scarano Michele,Parato Vito Maurizio,Dattilo Giuseppe,Casale Matteo

Publisher

Czech Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine

Link

http://e-coretvasa.cz/doi/10.33678/cor.2020.026.pdf

Reference16 articles.

1. Heart Failure

2. Ottawa (ON). Natriuretic Peptide Testing for Monitoring of Heart Failure Therapy: A Review of Clinical Effectiveness, Clinical Utility, Cost-Effectiveness, and Guidelines. Canadian Agency for Drugs and Technologies;Banerjee;in Health,2019

3. Clinical epidemiology of heart failure

4. Disease management programs in heart failure: half a century of an unmet need

5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ventricular tachycardia and non-Hodgkin's lymphoma. Syncope in a 33-year-old young;Cor et Vasa;2023-10-15

2. PaceMaker lead and atrial thrombosis, a rare event but of high clinical importance;Cor et Vasa;2022-09-01

3. PaceMaker lead and atrial thrombosis, a rare event but of high clinical importance;Cor et Vasa;2022-09-01

4. Chronic heart failure and hypotensive effects of sacubitril/valsartan. A clinical case;Cor et Vasa;2021-12-13

5. Amiodarone/sacubitril/valsartan;Reactions Weekly;2021-01